Kora Healthcare launches new Regelle, a Long Lasting Vaginal Moisturiser. One application of Regelle lasts three days and it is a water-based intravaginal gel providing soothing, continuous moisture and relief from symptoms of vaginal dryness, atrophy, itching, irritation and discomfort.
Regelle is a NON-hormonal preparation and can be used in conjunction with anti-oestrogens. Regelle comes in pre-filled applicators: 3 pack (9 days’ supply), 6 pack (18 days’ supply) and 12 pack (36 days’ supply) and is available on NHS prescription as well as Over the Counter (OTC) from all UK pharmacies.
Regelle is Kora’s latest addition to a range that includes Relactagel our non-antibiotic treatment for BV (Bacterial Vaginosis) which is also available as a prescription or OTC.
The Yes Yes Company
In 2006 The Yes Yes Company launched a range of innovative certified organic non- hormonal vaginal moisturisers and lubricants for use by women suffering from menopausal vaginal atrophy, dyspareunia and vulval disorders. Glycerine & paraben free, pH balanced and with a low osmolality range, YES is designed to be side-effect free, non-irritating and can be used in harmony with systemic and topical HRT especially when low dose vaginal oestrogen does not provide sufficient relief from symptoms.
Recommended by leading Health Care Professionals YES VM Vaginal Moisturising Gel and Yes water-based Intimate Lubricant in pre-filled applicators or tubes are available on prescription, and a wider range of products can be purchased OTC from www.yesyesyes.org. YES products offer a cost effective natural alternative to existing vaginal moisturisers.
Mylan ranks among the leading global generic and specialty pharmaceutical companies. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership.
In the UK, Mylan has one of the largest portfolio of generic and branded generic drugs, offering an extensive range of dosage forms and delivery systems. At Mylan we have one global quality standard in everything we do. Our internal teams conduct reviews of all products, start to finish. No matter where in the world they are made.
Why such high standards? Because we truly care about the people who will be helped by the medicines we make. And we believe in earning that trust from physicians, pharmacists, other health care professionals and patients, every day. This is why we say, “Our Mylan is Your Mylan.”
Cynosure, a Hologic Company, is a leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems. Our products are used to provide a diverse range of treatment applications. One such product is The MonaLisa Touch which is an innovative laser procedure, designed and produced by DEKA (Italy), that delivers fractional CO2 laser energy to the vaginal wall tissue for the treatment of Vaginal Atrophy, particularly those that are not able to tolerate topical oestrogens. The procedure is performed in an outpatient environment without the need for anaesthesia and with virtually no pain or side effects.
Besins Healthcare is a pharmaceutical company specialising in the development of innovative drugs for the well-being of men and women throughout their life.
Over the last 30 years, Besins has established a strong and reputable name in the production of drugs for the treatment of gynaecological, fertility and obstetrical conditions as well as androgen deficiency and has become a renowned player in the area of hormonal therapies.
Besins global commercial operations is based in the UK and our drugs are distributed in more than 90 countries via subsidiary companies (Besins affiliates) as well as a network of business partners. Besins is actively pursuing new growth opportunities through acquisition and expansion into new territories, bringing significant growth over the coming years.
Besins products are manufactured in a number of countries including France, Belgium and Spain.
To ensure we meet the needs of tomorrow, Besins has two primary research and development facilities across the globe. The research of the group is managed/handled by BHR Pharma, USA, which is an affiliate of Ascend Therapeutics, Inc.